Gallium 68 Psma-11 (BioDeep_00000229500)
human metabolite
代谢物信息卡片
Glu-NH-CO-NH-lys-(ahx)-((68)ga(hbed-CC))
化学式: C44H59GaN6O17 (1012.3192314)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: [H+].[68Ga+3].OC(=O)CC[C@H](NC(=O)N[C@@H](CCCCNC(=O)CCCCCNC(=O)CCC1=CC=C([O-])C(CN(CCN(CC([O-])=O)CC2=CC(CCC(O)=O)=CC=C2[O-])CC([O-])=O)=C1)C(O)=O)C(O)=O
InChI: InChI=1S/C44H62N6O17.Ga/c51-34-13-8-28(22-30(34)24-49(26-40(59)60)20-21-50(27-41(61)62)25-31-23-29(9-14-35(31)52)11-16-38(55)56)10-15-37(54)46-18-4-1-2-7-36(53)45-19-5-3-6-32(42(63)64)47-44(67)48-33(43(65)66)12-17-39(57)58
数据库引用编号
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Loic Ah-Thiane, Ludovic Ferrer, Bruno Maucherat, Vincent Fleury, Maelle Le Thiec, Daniela Rusu, Caroline Rousseau. Vaccine-Related Lymph Nodes: The Emerging Pitfalls of 18F-Fluorocholine and 68Ga-PSMA-11 PET/CT in the Era of COVID-19 Vaccination.
Clinical nuclear medicine.
2022 Jul; 47(7):575-582. doi:
10.1097/rlu.0000000000004190. [PMID: 35675134] - Hossein Jadvar. The VISION Forward: Recognition and Implication of PSMA-/18F-FDG+ mCRPC.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2022 06; 63(6):812-815. doi:
10.2967/jnumed.121.263274. [PMID: 34933889] - Carlo Greco, Oriol Pares, Nuno Pimentel, Vasco Louro, Beatriz Nunes, Justyna Kociolek, João Marques, Zvi Fuks. Early PSA density kinetics predicts biochemical and local failure following extreme hypofractionated radiotherapy in intermediate-risk prostate cancer.
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
2022 04; 169(?):35-42. doi:
10.1016/j.radonc.2022.02.016. [PMID: 35189157] - Theresa Leder, Robert Drescher, Falk Gühne, Bernhard Theis, Martin Freesmeyer. De Quervain Subacute Thyroiditis With Moderate PSMA Uptake Mimicking Thyroid Metastasis of Renal Cell Carcinoma.
Clinical nuclear medicine.
2022 Mar; 47(3):221-222. doi:
10.1097/rlu.0000000000003952. [PMID: 34690294] - Ismet Sarikaya, Ahmed Alqallaf, Ali Sarikaya, Ali Baqer, Nafisa Kazem. Renal Cortical Scarring: 68Ga-PSMA-11 PET Versus 99mTc-DMSA Scanning in a Case of Pyelonephritis.
Journal of nuclear medicine technology.
2022 Mar; 50(1):49-53. doi:
10.2967/jnmt.121.262415. [PMID: 34330812] - Jan-Henning Schierz, Ismet Sarikaya, Ahmed N Albatineh, Ali Sarikaya. Assessing the Correlation Between 68Ga-PSMA-11 Renal PET Parameters and Renal Function Tests.
Journal of nuclear medicine technology.
2022 Mar; 50(1):43-48. doi:
10.2967/jnmt.121.262462. [PMID: 34330809] - Zahra Bakhshi Golestani, Salman Soltani, Mahmoud Reza Kalantari, Hamid Reza Ghorbani, Atena Aghaee. Rare Case of Small Cell Metastatic Prostatic Adenocarcinoma, Properly Staged by 68Ga-PSMA PET/CT Scan.
Clinical nuclear medicine.
2022 Mar; 47(3):e259-e261. doi:
10.1097/rlu.0000000000004033. [PMID: 35025791] - Soheila Erfani, Ramin Sadeghi, Atena Aghaee, HamidReza Ghorbani, Vahid Roshanravan. Prostate-Specific Membrane Antigen Radioguided Surgery for Salvage Pelvic Lymph Node Dissection in a Man With Prostate Cancer.
Clinical nuclear medicine.
2022 Feb; 47(2):e174-e176. doi:
10.1097/rlu.0000000000003944. [PMID: 34690293] - Parwiz Abrahimi, Timothy McClure. Emerging Intraoperative Imaging Technologies in Urologic Oncology.
The Urologic clinics of North America.
2022 Feb; 49(1):57-63. doi:
10.1016/j.ucl.2021.08.002. [PMID: 34776054] - Liu Xiao, Haitao Wang, Yuhao Li. A case of 68Ga-PSMA PET early dynamic image revealing occult recurrent lesion in the posterior wall of the urinary bladder.
Hellenic journal of nuclear medicine.
2022 Jan; 25(1):111-112. doi:
10.1967/s002449912446. [PMID: 35503559] - Hasan Önner, Farise Yılmaz. Characterization of bone metastases detected on 68Ga-PSMA PET/CT in newly diagnosed prostate cancer.
Hellenic journal of nuclear medicine.
2022 Jan; 25(1):57-62. doi:
10.1967/s002449912443. [PMID: 35503556] - Melis Oflas, Yasemin Ozluk, Oner Sanli, Zeynep Gozde Ozkan, Serkan Kuyumcu. 68Ga-PSMA Uptake Patterns of Clear Cell Renal Carcinoma Across Different Histopathological Subtypes.
Clinical nuclear medicine.
2022 Jan; 47(1):e45-e46. doi:
10.1097/rlu.0000000000003814. [PMID: 34284482] - Burcin Karasah Erkek, Özgür Ömür, Serdar Özkök, Burak Turna. COVID-19 Lung Findings Detected by 68Ga-PSMA PET/CT for Staging Purposes in Patients With Prostate Cancer.
Clinical nuclear medicine.
2022 Jan; 47(1):e17-e19. doi:
10.1097/rlu.0000000000003723. [PMID: 34028424] - Christian Uprimny, Steffen Bayerschmidt, Alexander Stephan Kroiss, Josef Fritz, Bernhard Nilica, Hanna Svirydenka, Clemens Decristoforo, Elisabeth von Guggenberg, Wolfgang Horninger, Irene Johanna Virgolini. Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2021 11; 62(11):1550-1557. doi:
10.2967/jnumed.120.261866. [PMID: 33712533] - Nuh Filizoglu, Ilknur Alsan Cetin, Tugba Nergiz Kissa, Khanim Niftaliyeva, Tunc Ones. 68Ga-PSMA PET/CT to Distinguish Brain Metastasis of Renal Cell Carcinoma From Radiation Necrosis After Stereotactic Radiosurgery.
Clinical nuclear medicine.
2021 Nov; 46(11):913-914. doi:
10.1097/rlu.0000000000003820. [PMID: 34284481] - Ashwini Kalshetty, Biju Menon, Sutapa Rakshit, Atanu Bhattacharjee, Sandip Basu. Correlation of Lesional Uptake Parameters and Ratios with miPSMA Score and Estimating Normal Physiologic Concentration: An Exploratory Analysis in Metastatic Castration-Resistant Prostatic Carcinoma Patients with 68Ga-PSMA-11 PET/CT.
Journal of nuclear medicine technology.
2021 Sep; 49(3):235-240. doi:
10.2967/jnmt.120.261289. [PMID: 34244223] - Guofan Xu, Yang Lu. Optimal Time Point for 68Ga-PSMA-11 PET/CT Imaging in the Assessment of Suspected Metastatic Prostate Cancer in the Bladder of Postprostatectomy Patient.
Clinical nuclear medicine.
2021 Aug; 46(8):675-676. doi:
10.1097/rlu.0000000000003533. [PMID: 33577202] - Duygu Has Simsek, Caner Civan, Selcuk Erdem, Yasemin Sanli. Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.
Clinical nuclear medicine.
2021 Jul; 46(7):579-581. doi:
10.1097/rlu.0000000000003590. [PMID: 33782292] - Huijuan Liu, Yuhong Liu, Yue Chen, Huipan Liu. 68Ga-PSMA Uptake in Pulmonary Tuberculosis: A Pitfall in Prostate Cancer PET Imaging.
Nuklearmedizin. Nuclear medicine.
2021 06; 60(3):252-253. doi:
10.1055/a-1312-6148. [PMID: 33302315] - Shay Golan, Tzach Aviv, David Groshar, Maxim Yakimov, Yaniv Zohar, Yoad Prokocimer, Andrei Nadu, Jack Baniel, Liran Domachevsky, Hanna Bernstine. Dynamic 68Ga-PSMA-11 PET/CT for the Primary Evaluation of Localized Renal Mass: A Prospective Study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2021 06; 62(6):773-778. doi:
10.2967/jnumed.120.251272. [PMID: 33097628] - Habibollah Dadgar, Nasim Norouzbeigi, Ali Gholamrezanezhad, Majid Assadi. Incidental Detections Suggestive of COVID-19 in Asymptomatic Patients Undergoing 68Ga-DOTATATE and 68Ga-PSMA-11 PET-CT Scan for Oncological Indications.
Nuklearmedizin. Nuclear medicine.
2021 04; 60(2):106-108. doi:
10.1055/a-1311-2856. [PMID: 33327007] - Ismet Sarikaya, Ahmed Alqallaf, Ali Sarikaya. Renal Cortical 68Ga-PSMA-11 PET and 99mTc-DMSA Images.
Journal of nuclear medicine technology.
2021 Mar; 49(1):30-33. doi:
10.2967/jnmt.120.248922. [PMID: 32887764] - Ricardo Alvim, Karan Nagar, Sudeep Das, Souhil Lebdai, Nathan Wong, Alexander Somma, Christopher Hughes, Jasmine Thomas, Sébastien Monette, Avigdor Scherz, Kwanghee Kim, Jan Grimm, Jonathan A Coleman. Positron Emission Tomography/Computed Tomography with Gallium-68-labeled Prostate-specific Membrane Antigen Detects Relapse After Vascular-targeted Photodynamic Therapy in a Prostate Cancer Model.
European urology focus.
2021 03; 7(2):472-478. doi:
10.1016/j.euf.2019.06.008. [PMID: 31227464] - Le-Le Zhang, Wen-Cheng Li, Zheng Xu, Nan Jiang, Shi-Ming Zang, Lu-Wei Xu, Wen-Bing Huang, Feng Wang, Hong-Bin Sun. 68Ga-PSMA PET/CT targeted biopsy for the diagnosis of clinically significant prostate cancer compared with transrectal ultrasound guided biopsy: a prospective randomized single-centre study.
European journal of nuclear medicine and molecular imaging.
2021 02; 48(2):483-492. doi:
10.1007/s00259-020-04863-2. [PMID: 32734457] - Camila Edith Stachera Stasiak, Fabrícius Rocha Cardoso, Sergio Altino de Almeida, Paulo Henrique Rosado-de-Castro. Incidental finding of COVID-19 infection after [68Ga]Ga-PSMA-11 PET/CT imaging in a patient with prostate cancer.
European journal of nuclear medicine and molecular imaging.
2021 02; 48(2):653-654. doi:
10.1007/s00259-020-04932-6. [PMID: 32710224] - Jie Gao, Qinfeng Xu, Yao Fu, Kuiqiang He, Chengwei Zhang, Qing Zhang, Jiong Shi, Xiaozhi Zhao, Feng Wang, Hongqian Guo. Comprehensive evaluation of 68Ga-PSMA-11 PET/CT parameters for discriminating pathological characteristics in primary clear-cell renal cell carcinoma.
European journal of nuclear medicine and molecular imaging.
2021 02; 48(2):561-569. doi:
10.1007/s00259-020-04916-6. [PMID: 32623502] - Jing-Ren Tseng, Kai-Jie Yu, Feng-Yuan Liu, Lan-Yan Yang, Ji-Hong Hong, Tzu-Chen Yen, See-Tong Pang, Li-Jen Wang. Comparison between 68Ga-PSMA-11 PET/CT and multiparametric magnetic resonance imaging in patients with biochemically recurrent prostate cancer following robot-assisted radical prostatectomy.
Journal of the Formosan Medical Association = Taiwan yi zhi.
2021 Jan; 120(1 Pt 3):688-696. doi:
10.1016/j.jfma.2020.07.029. [PMID: 32739147] - Zeinab Khansa, Nemer Neaimeh, Mahmoud Korek, Mohamad Haidar. Can SUVmax of 68Ga-labeled PSMA Ligand and 18F-choline PET/CT Be Used to Predict the Radiation Dose in Prostate Cancer Patients?.
Health physics.
2021 01; 120(1):80-85. doi:
10.1097/hp.0000000000001287. [PMID: 32826522] - Meltem Caglar, Murat Tuncel, Egemen Yildiz, Erdem Karabulut. Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT.
Annals of nuclear medicine.
2020 Dec; 34(12):932-941. doi:
10.1007/s12149-020-01529-9. [PMID: 32975741] - Sarai Morón, Eliana González, Julián Rojas. 68Ga-PSMA PET/CT With Incidental Finding of COVID-19 in an Asymptomatic Patient.
Clinical nuclear medicine.
2020 Dec; 45(12):1032-1033. doi:
10.1097/rlu.0000000000003388. [PMID: 33065616] - Shobhana Raju, Anshul Sharma, Chetan Patel, Ranjith Sahoo, Chandan J Das, Sanjay Kumar, Akshima Sharma, Rakesh Kumar. Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?.
Nuclear medicine communications.
2020 Nov; 41(11):1183-1188. doi:
10.1097/mnm.0000000000001268. [PMID: 32796451] - Liang Dong, Yinjie Zhu, Mei Xin, Baijun Dong, Jiahua Pan, Jianjun Liu, Sarah R Amend, Wei Xue, Kenneth J Pienta, Steven P Rowe. Prospective evaluation of 68Ga-PSMA-11 PET/CT in Chinese men with biochemical recurrence after radical prostatectomy for prostate cancer: relationships between location of recurrence, time after prostatectomy, and serum PSA level.
Medical oncology (Northwood, London, England).
2020 Sep; 37(10):89. doi:
10.1007/s12032-020-01412-7. [PMID: 32920666] - Chen Liu, Teli Liu, Zhongyi Zhang, Ning Zhang, Peng Du, Yong Yang, Yiqiang Liu, Wei Yu, Nan Li, Michael A Gorin, Steven P Rowe, Hua Zhu, Kun Yan, Zhi Yang. 68Ga-PSMA PET/CT Combined with PET/Ultrasound-Guided Prostate Biopsy Can Diagnose Clinically Significant Prostate Cancer in Men with Previous Negative Biopsy Results.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2020 09; 61(9):1314-1319. doi:
10.2967/jnumed.119.235333. [PMID: 32034111] - Maura Scarlattei, Giorgio Baldari, Mario Silva, Stefano Bola, Antonino Sammartano, Silvia Migliari, Tiziano Graziani, Carla Cidda, Nicola Sverzellati, Livia Ruffini. Unknown SARS-CoV-2 pneumonia detected by PET/CT in patients with cancer.
Tumori.
2020 Aug; 106(4):325-332. doi:
10.1177/0300891620935983. [PMID: 32567505] - Ew-Jun Chen, Teik Hin Tan, Ming Tsuey Chew, Ping Ching Chye. 68Ga-PSMA PET/CT and 18F-FDG PET/CT in Renal Cell Carcinoma.
Clinical nuclear medicine.
2020 Jul; 45(7):e317-e319. doi:
10.1097/rlu.0000000000003053. [PMID: 32404702] - Turkay Hekimsoy, Gozde Daglioz Gorur, Serkan Isgoren, Hande Uslu, Hakan Demir. Urinary Reflux Into the Prostate Gland and Seminal Vesicles: A Potential Pitfall in 18F-FDG and 68Ga-PSMA PET/CT.
Clinical nuclear medicine.
2020 Jul; 45(7):536-537. doi:
10.1097/rlu.0000000000003069. [PMID: 32433177] - Mark A Green, Gary D Hutchins, Clinton D Bahler, Mark Tann, Carla J Mathias, Wendy Territo, Justin Sims, Heather Polson, David Alexoff, William C Eckelman, Hank F Kung, James W Fletcher. [68Ga]Ga-P16-093 as a PSMA-Targeted PET Radiopharmaceutical for Detection of Cancer: Initial Evaluation and Comparison with [68Ga]Ga-PSMA-11 in Prostate Cancer Patients Presenting with Biochemical Recurrence.
Molecular imaging and biology.
2020 06; 22(3):752-763. doi:
10.1007/s11307-019-01421-7. [PMID: 31429050] - Cem Onal, Nese Torun, Ezgi Oymak, Ozan C Guler, Mehmet Reyhan, Ali F Yapar. Retrospective correlation of 68ga-psma uptake with clinical parameters in prostate cancer patients undergoing definitive radiotherapy.
Annals of nuclear medicine.
2020 Jun; 34(6):388-396. doi:
10.1007/s12149-020-01462-x. [PMID: 32221791] - Cigdem Soydal, Yuksel Urun, Evren Suer, Demet Nak, Elgin Ozkan, Nuriye O Kucuk. Predictor of 68Ga PSMA PET/CT positivity in patients with prostate cancer.
The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of....
2020 Jun; 64(2):226-230. doi:
10.23736/s1824-4785.18.03056-x. [PMID: 29745629] - Cem Onal, Ozan Cem Guler, Nese Torun, Mehmet Reyhan, Ali Fuat Yapar. The effect of androgen deprivation therapy on 68Ga-PSMA tracer uptake in non-metastatic prostate cancer patients.
European journal of nuclear medicine and molecular imaging.
2020 03; 47(3):632-641. doi:
10.1007/s00259-019-04581-4. [PMID: 31732768] - Pir Abdul Ahad Aziz Qureshi, Namra Asghar, Humayun Bashir, Imran Khalid Niazi, Noreen Akhtar. The Hot Pleura: Isolated Pleural Metastases From Renal Cell Carcinoma.
Clinical nuclear medicine.
2020 Mar; 45(3):211-213. doi:
10.1097/rlu.0000000000002909. [PMID: 31977468] - Kelsey L Pomykala, Johannes Czernin, Tristan R Grogan, Wesley R Armstrong, John Williams, Jeremie Calais. Total-Body 68Ga-PSMA-11 PET/CT for Bone Metastasis Detection in Prostate Cancer Patients: Potential Impact on Bone Scan Guidelines.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2020 03; 61(3):405-411. doi:
10.2967/jnumed.119.230318. [PMID: 31541035] - Aloÿse Fourquet, Cyrielle Aveline, Olivier Cussenot, Gilles Créhange, Françoise Montravers, Jean-Noël Talbot, Mathieu Gauthé. 68Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients' disease management and adequacy of impact.
Scientific reports.
2020 02; 10(1):2104. doi:
10.1038/s41598-020-58975-8. [PMID: 32034191] - Feifei Zhang, Yao Fu, Mengxia Chen, Feng Wang, Xuefeng Qiu, Hongqian Guo. Renal Pelvis Metastasis From Prostatic Adenocarcinoma Missed by PSMA PET: A Case Report.
Urology.
2020 Feb; 136(?):e3-e4. doi:
10.1016/j.urology.2019.11.005. [PMID: 31733274] - Wojciech Cytawa, Anna Katharina Seitz, Stefan Kircher, Kazuhito Fukushima, Johannes Tran-Gia, Andreas Schirbel, Tomasz Bandurski, Piotr Lass, Markus Krebs, Wojciech Połom, Marcin Matuszewski, Hans-Jürgen Wester, Andreas K Buck, Hubert Kübler, Constantin Lapa. 68Ga-PSMA I&T PET/CT for primary staging of prostate cancer.
European journal of nuclear medicine and molecular imaging.
2020 01; 47(1):168-177. doi:
10.1007/s00259-019-04524-z. [PMID: 31529265] - Bernhard Grubmüller, Sazan Rasul, Pascal Baltzer, Harun Fajkovic, David D'Andrea, Florian Berndl, Agnes Maj-Hes, Karl Hermann Grubmüller, Markus Mitterhauser, Wolfgang Wadsak, Sarah Pfaff, Shahrokh F Shariat, Marcus Hacker, Gero Kramer, Markus Hartenbach. Response assessment using [68 Ga]Ga-PSMA ligand PET in patients undergoing systemic therapy for metastatic castration-resistant prostate cancer.
The Prostate.
2020 01; 80(1):74-82. doi:
10.1002/pros.23919. [PMID: 31614001] - Asim Kichloo, Rawan Amir, Michael Aljadah, Farah Wani, Shantanu Solanki, Jagmeet Singh, Savneek Singh Chugh. FDG-PET Versus PSMA-PET: A Patient With Prostate Cancer.
Journal of investigative medicine high impact case reports.
2020 Jan; 8(?):2324709620941313. doi:
10.1177/2324709620941313. [PMID: 32646251] - Kerstin Michalski, Michael Mix, Philipp T Meyer, Juri Ruf. Determination of whole-body tumour burden on [68Ga]PSMA-11 PET/CT for response assessment of [177Lu]PSMA-617 radioligand therapy: a retrospective analysis of serum PSA level and imaging derived parameters before and after two cycles of therapy.
Nuklearmedizin. Nuclear medicine.
2019 Dec; 58(6):443-450. doi:
10.1055/a-1035-9052. [PMID: 31724145] - Priyamvada Gupta, Vedang Murthy, Archi Agarwal, Madan Maitre, Nihit Mhatre, Venkatesh Rangarajan. 68Ga-prostate-specific membrane antigen PETCT-based response to androgen deprivation therapy in patients with prostate cancer.
Nuclear medicine communications.
2019 Dec; 40(12):1283-1288. doi:
10.1097/mnm.0000000000001105. [PMID: 31688498] - Nikhil Seniaray, Ritu Verma, Ethel Belho, Dharmender Malik, Harsh Mahajan. Diffuse Pulmonary Metastases From Prostate Cancer on 68Ga PSMA PET/CT.
Clinical nuclear medicine.
2019 Nov; 44(11):898-900. doi:
10.1097/rlu.0000000000002753. [PMID: 31361647] - Christian Schmidkonz, Michael Cordes, Theresa Ida Goetz, Olaf Prante, Torsten Kuwert, Philipp Ritt, Michael Uder, Bernd Wullich, Peter Goebell, Tobias Bäuerle. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Annals of nuclear medicine.
2019 Oct; 33(10):766-775. doi:
10.1007/s12149-019-01387-0. [PMID: 31338731] - Sheliyan Raveenthiran, Rachel Esler, John Yaxley, Sam Kyle. The use of 68Ga-PET/CT PSMA in the staging of primary and suspected recurrent renal cell carcinoma.
European journal of nuclear medicine and molecular imaging.
2019 Oct; 46(11):2280-2288. doi:
10.1007/s00259-019-04432-2. [PMID: 31332498] - Tima Davidson, Uri Amit, Akram Saad, Maia Hahiashvili, Elinor Goshen, Orith Portnoy, Raanan Berger, Adam Goldstein, Igor Sadetsky, Noam Weizman, Bar Chikman, Zohar Dotan, Yaacov R Lawrence, Simona Ben-Haim, Zvi Symon, Jeff Goldstein. Gallium-68 prostate-specific membrane antigen PET-CT and the clinical management of prostate cancer.
Nuclear medicine communications.
2019 Sep; 40(9):913-919. doi:
10.1097/mnm.0000000000001047. [PMID: 31343612] - Andrei Gafita, Marie Bieth, Markus Krönke, Giles Tetteh, Fernando Navarro, Hui Wang, Elisabeth Günther, Bjoern Menze, Wolfgang A Weber, Matthias Eiber. qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using 68Ga-PSMA11 PET/CT.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2019 09; 60(9):1277-1283. doi:
10.2967/jnumed.118.224055. [PMID: 30850484] - Caroline Rousseau, Maelle Le Thiec, Ludovic Ferrer, Daniela Rusu, Aurore Rauscher, Bruno Maucherat, Mathieu Frindel, Pierre Baumgartner, Vincent Fleury, Antoine Denis, Agnes Morel, Nicolas Varmenot, Emilie Debeaupuis, Loic Campion, Francoise Kraeber-Bodéré. Preliminary results of a 68 Ga-PSMA PET/CT prospective study in prostate cancer patients with occult recurrence: Diagnostic performance and impact on therapeutic decision-making.
The Prostate.
2019 09; 79(13):1514-1522. doi:
10.1002/pros.23869. [PMID: 31421657] - Jonathan Damjanovic, Jan-Carlo Janssen, Vikas Prasad, Gerd Diederichs, Thula Walter, Winfried Brenner, Marcus R Makowski. 68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer.
Cancer imaging : the official publication of the International Cancer Imaging Society.
2019 Jun; 19(1):37. doi:
10.1186/s40644-019-0220-x. [PMID: 31186052] - Conrad Leitsmann, Paul Thelen, Marianne Schmid, Johannes Meller, Carsten-Oliver Sahlmann, Birgit Meller, Lutz Trojan, Arne Strauss. Enhancing PSMA-uptake with androgen deprivation therapy - a new way to detect prostate cancer metastases?.
International braz j urol : official journal of the Brazilian Society of Urology.
2019 May; 45(3):459-467. doi:
10.1590/s1677-5538.ibju.2018.0305. [PMID: 30901173] - Matthieu Barbaud, Mathieu Frindel, Ludovic Ferrer, Maelle Le Thiec, Daniela Rusu, Aurore Rauscher, Bruno Maucherat, Pierre Baumgartner, Vincent Fleury, Mathilde Colombié, Agnes Thierry-Morel, Françoise Kraeber-Bodéré, Loïc Campion, Caroline Rousseau. 68Ga-PSMA-11 PET-CT study in prostate cancer patients with biochemical recurrence and non-contributive 18F-Choline PET-CT: Impact on therapeutic decision-making and biomarker changes.
The Prostate.
2019 04; 79(5):454-461. doi:
10.1002/pros.23751. [PMID: 30549066] - Mike Sathekge, Frank Bruchertseifer, Otto Knoesen, Florette Reyneke, Ismaheel Lawal, Thabo Lengana, Cindy Davis, Johncy Mahapane, Ceceila Corbett, Mariza Vorster, Alfred Morgenstern. 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.
European journal of nuclear medicine and molecular imaging.
2019 01; 46(1):129-138. doi:
10.1007/s00259-018-4167-0. [PMID: 30232539] - Etienne Rousseau, Joseph Lau, Hsiou-Ting Kuo, Zhengxing Zhang, Helen Merkens, Navjit Hundal-Jabal, Nadine Colpo, Kuo-Shyan Lin, François Bénard. Monosodium Glutamate Reduces 68Ga-PSMA-11 Uptake in Salivary Glands and Kidneys in a Preclinical Prostate Cancer Model.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2018 12; 59(12):1865-1868. doi:
10.2967/jnumed.118.215350. [PMID: 30097503] - Emre Demirci, Türkay Toklu, Nami Yeyin, Meltem Ocak, Nalan Alan-Selcuk, Ahmet Araman, Levent Kabasakal. ESTIMATION OF THE ORGAN ABSORBED DOSES AND EFFECTIVE DOSE FROM 68Ga-PSMA-11 PET SCAN.
Radiation protection dosimetry.
2018 Dec; 182(4):518-524. doi:
10.1093/rpd/ncy111. [PMID: 30137614] - Christian Schmidkonz, Michael Cordes, Daniela Schmidt, Tobias Bäuerle, Theresa Ida Goetz, Michael Beck, Olaf Prante, Alexander Cavallaro, Michael Uder, Bernd Wullich, Peter Goebell, Torsten Kuwert, Philipp Ritt. 68Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancer.
European journal of nuclear medicine and molecular imaging.
2018 10; 45(11):1862-1872. doi:
10.1007/s00259-018-4042-z. [PMID: 29725716] - Ahmed Eissa, Ahmed Elsherbiny, Rafael F Coelho, Jens Rassweiler, John W Davis, Francesco Porpiglia, Vipul R Patel, Napoleone Prandini, Salvatore Micali, Maria Chiara Sighinolfi, Stefano Puliatti, Bernardo Rocco, Giampaolo Bianchi. The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature.
Minerva urologica e nefrologica = The Italian journal of urology and nephrology.
2018 Oct; 70(5):462-478. doi:
10.23736/s0393-2249.18.03081-3. [PMID: 29664244] - Hsiou-Ting Kuo, Jinhe Pan, Zhengxing Zhang, Joseph Lau, Helen Merkens, Chengcheng Zhang, Nadine Colpo, Kuo-Shyan Lin, François Bénard. Effects of Linker Modification on Tumor-to-Kidney Contrast of 68Ga-Labeled PSMA-Targeted Imaging Probes.
Molecular pharmaceutics.
2018 08; 15(8):3502-3511. doi:
10.1021/acs.molpharmaceut.8b00499. [PMID: 29920108] - Peter Bronsert, Kathrin Reichel, Juri Ruf. Loss of PSMA Expression in Non-neuroendocrine Dedifferentiated Acinar Prostate Cancer.
Clinical nuclear medicine.
2018 Jul; 43(7):526-528. doi:
10.1097/rlu.0000000000002100. [PMID: 29659395] - Arun Sasikumar, Ajith Joy, M R A Pillai, Karuna Elza Oommen, R Jayakumar. Rare Case of Intratracheal Metastasis Detected on 68Ga-Prostate-Specific Membrane Antigen PET/CT Scan in a Case of Thyroglobulin Elevated Negative Iodine Scan Syndrome.
Clinical nuclear medicine.
2018 Apr; 43(4):282-283. doi:
10.1097/rlu.0000000000001992. [PMID: 29432341] - Mads Ryø Jochumsen, Lars Christian Gormsen, Gitte Lund Nielsen. 68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.
Clinical nuclear medicine.
2018 Feb; 43(2):117-119. doi:
10.1097/rlu.0000000000001935. [PMID: 29261620] - Jeremie Calais, Johannes Czernin, Minsong Cao, Amar U Kishan, John V Hegde, Narek Shaverdian, Kiri Sandler, Fang-I Chu, Chris R King, Michael L Steinberg, Isabel Rauscher, Nina-Sophie Schmidt-Hegemann, Thorsten Poeppel, Philipp Hetkamp, Francesco Ceci, Ken Herrmann, Wolfgang P Fendler, Matthias Eiber, Nicholas G Nickols. 68Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2018 02; 59(2):230-237. doi:
10.2967/jnumed.117.201749. [PMID: 29123013] - Mike Sathekge, Thabo Lengana, Alex Maes, Mariza Vorster, JanRijn Zeevaart, Ismaheel Lawal, Thomas Ebenhan, Christophe Van de Wiele. 68Ga-PSMA-11 PET/CT in primary staging of prostate carcinoma: preliminary results on differences between black and white South-Africans.
European journal of nuclear medicine and molecular imaging.
2018 Feb; 45(2):226-234. doi:
10.1007/s00259-017-3852-8. [PMID: 29101444] - Christian Filss, Alexander Heinzel, Berthold Miiller, Andreas T J Vogg, Karl-Josef Langen, Felix M Mottaghy. Relevant tumor sink effect in prostate cancer patients receiving 177Lu-PSMA-617 radioligand therapy.
Nuklearmedizin. Nuclear medicine.
2018 Feb; 57(1):19-25. doi:
10.3413/nukmed-0937-17-10. [PMID: 29536496] - Amir Iravani, Michael S Hofman, Tony Mulcahy, Scott Williams, Declan Murphy, Bimal K Parameswaran, Rodney J Hicks. 68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer.
Cancer imaging : the official publication of the International Cancer Imaging Society.
2017 Dec; 17(1):31. doi:
10.1186/s40644-017-0133-5. [PMID: 29268784] - Sebastian Schmuck, Christoph A von Klot, Christoph Henkenberens, Jan M Sohns, Hans Christiansen, Hans-Jürgen Wester, Tobias L Ross, Frank M Bengel, Thorsten Derlin. Initial Experience with Volumetric 68Ga-PSMA I&T PET/CT for Assessment of Whole-Body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate Cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2017 12; 58(12):1962-1968. doi:
10.2967/jnumed.117.193581. [PMID: 28522740] - Louise Emmett, Pim J van Leeuwen, Rohan Nandurkar, Matthijs J Scheltema, Thomas Cusick, George Hruby, Andrew Kneebone, Thomas Eade, Gerald Fogarty, Raj Jagavkar, Quoc Nguyen, Bao Ho, Anthony M Joshua, Phillip Stricker. Treatment Outcomes from 68Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2017 12; 58(12):1972-1976. doi:
10.2967/jnumed.117.196683. [PMID: 28747524] - Federica Matteucci, Emilio Mezzenga, Paola Caroli, Valentina Di Iorio, Anna Sarnelli, Monica Celli, Lorenzo Fantini, Andrea Moretti, Riccardo Galassi, Ugo De Giorgi, Giovanni Paganelli. Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results.
European journal of nuclear medicine and molecular imaging.
2017 Dec; 44(13):2189-2194. doi:
10.1007/s00259-017-3791-4. [PMID: 28801787] - Danielle P Meyrick, Marcus Asokendaran, Laura A Skelly, Nat P Lenzo, Andrew Henderson. The role of 68Ga-PSMA-I&T PET/CT in the pretreatment staging of primary prostate cancer.
Nuclear medicine communications.
2017 Nov; 38(11):956-963. doi:
10.1097/mnm.0000000000000738. [PMID: 28922335] - Courtney Lawhn-Heath, Robert R Flavell, Christine Glastonbury, Thomas A Hope, Spencer C Behr. Incidental Detection of Head and Neck Squamous Cell Carcinoma on 68Ga-PSMA-11 PET/CT.
Clinical nuclear medicine.
2017 Apr; 42(4):e218-e220. doi:
10.1097/rlu.0000000000001569. [PMID: 28166149] - Helle D Zacho, Julie B Nielsen, Katja Dettmann, Uwe Haberkorn, Lars J Petersen. Incidental Detection of Thyroid Metastases From Renal Cell Carcinoma Using 68Ga-PSMA PET/CT to Assess Prostate Cancer Recurrence.
Clinical nuclear medicine.
2017 Mar; 42(3):221-222. doi:
10.1097/rlu.0000000000001522. [PMID: 28033223] - Lino M Sawicki, Christian Buchbender, Johannes Boos, Markus Giessing, Johannes Ermert, Christina Antke, Gerald Antoch, Hubertus Hautzel. Diagnostic potential of PET/CT using a 68Ga-labelled prostate-specific membrane antigen ligand in whole-body staging of renal cell carcinoma: initial experience.
European journal of nuclear medicine and molecular imaging.
2017 Jan; 44(1):102-107. doi:
10.1007/s00259-016-3360-2. [PMID: 26996777] - Arun Sasikumar, Ajith Joy, Raviteja Nanabala, Madhavan Unni, Padmanabhan Tk. Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma.
Clinical nuclear medicine.
2016 Dec; 41(12):e517-e519. doi:
10.1097/rlu.0000000000001394. [PMID: 27749421] - Ali Afshar-Oromieh, Henrik Hetzheim, Clemens Kratochwil, Martina Benesova, Matthias Eder, Oliver C Neels, Michael Eisenhut, Wolfgang Kübler, Tim Holland-Letz, Frederik L Giesel, Walter Mier, Klaus Kopka, Uwe Haberkorn. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2015 Nov; 56(11):1697-705. doi:
10.2967/jnumed.115.161299. [PMID: 26294298] - Markus Dietlein, Carsten Kobe, Georg Kuhnert, Simone Stockter, Thomas Fischer, Klaus Schomäcker, Matthias Schmidt, Felix Dietlein, Boris D Zlatopolskiy, Philipp Krapf, Raphael Richarz, Stephan Neubauer, Alexander Drzezga, Bernd Neumaier. Comparison of [(18)F]DCFPyL and [ (68)Ga]Ga-PSMA-HBED-CC for PSMA-PET Imaging in Patients with Relapsed Prostate Cancer.
Molecular imaging and biology.
2015 Aug; 17(4):575-84. doi:
10.1007/s11307-015-0866-0. [PMID: 26013479] - Ken Herrmann, Christina Bluemel, Martina Weineisen, Margret Schottelius, Hans-Jürgen Wester, Johannes Czernin, Uta Eberlein, Seval Beykan, Constantin Lapa, Hubertus Riedmiller, Markus Krebs, Saskia Kropf, Andreas Schirbel, Andreas K Buck, Michael Lassmann. Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
2015 Jun; 56(6):855-61. doi:
10.2967/jnumed.115.156133. [PMID: 25883128] - Jules Lavalaye, Marnix G E H Lam, J F Fred Verzijlbergen, Gerard C Krijger, Roeland Vis, Bart de Keizer. [Not Available].
Nederlands tijdschrift voor geneeskunde.
2015; 160(?):A9780. doi:
NULL. [PMID: 27142500] - Emre Demirci, Meltem Ocak, Levent Kabasakal, Clemens Decristoforo, Zübeyir Talat, Metin Halaç, Bedii Kanmaz. (68)Ga-PSMA PET/CT imaging of metastatic clear cell renal cell carcinoma.
European journal of nuclear medicine and molecular imaging.
2014 Jul; 41(7):1461-2. doi:
10.1007/s00259-014-2766-y. [PMID: 24756358]